Online citations, reference lists, and bibliographies.

Human Papillomavirus And Oropharyngeal Cancer.

Takako Imai Tanaka, Faizan Alawi
Published 2018 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC) comprises approximately 25% of all head and neck cancers (head and neck squamous cell carcinoma, HNSCC). Epidemiologic studies have shown a dramatic increase of HPV-OPSCC in the past 2 decades, whereas tobacco-related HNSCC rates are decreasing worldwide. The distinctions between HPV-OPSCC and oral cavity cancers are now reflected in the most recent editions of the World Health Organization Classification of Tumors of the Head and Neck and the American Joint Committee on Cancer Staging Manual, respectively. This review describes current understanding of the link between HPV infection and OPSCC.
This paper references
10.18632/oncotarget.16747
Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma
Chung-Guei Huang (2017)
10.1038/nrc798
Papillomaviruses and cancer: from basic studies to clinical application
Harald Hausen (2002)
10.1001/jamaoncol.2016.6192
Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014
Jasmine J. Han (2017)
10.1080/00016480601110170
The incidence of tonsillar cancer in Sweden is increasing
>Lalle Hammarstedt (2007)
10.1200/JCO.2015.61.6995
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.
Maura L. Gillison (2015)
10.1200/JCO.2013.50.3870
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.
Anil K Chaturvedi (2013)
10.1200/JCO.2007.14.1713
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.
Anil K Chaturvedi (2008)
10.1016/j.oraloncology.2016.03.003
Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus.
Mark E Zafereo (2016)
10.1200/JCO.2011.36.4596
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
Anil K Chaturvedi (2011)
10.15585/mmwr.mm6526a1
Human Papillomavirus-Associated Cancers - United States, 2008-2012.
Laura J Viens (2016)
10.1056/NEJMoa065497
Case-control study of human papillomavirus and oropharyngeal cancer.
Gypsyamber D’souza (2007)
10.6004/JNCCN.2015.0102
Head and Neck Cancers, Version 1.2015.
David G. Pfister (2015)
10.1097/PAS.0b013e318265fb2b
Detection of Transcriptionally Active High-risk HPV in Patients With Head and Neck Squamous Cell Carcinoma as Visualized by a Novel E6/E7 mRNA In Situ Hybridization Method
Justin A. Bishop (2012)
10.1371/journal.pone.0068329
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
Rolando Herrero (2013)
10.1093/jnci/djv086
US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
Mona Saraiya (2015)
10.1177/0194599815592157
HPV-Positive Oropharyngeal Carcinoma
Marilene B Wang (2015)
10.3322/caac.21388
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.
Mahul B. Amin (2017)
10.1016/j.oraloncology.2016.01.002
Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis.
Parish P Sedghizadeh (2016)
10.1002/cncr.29921
Rising population of survivors of oral squamous cell cancer in the United States.
Mira A. Patel (2016)
10.3322/caac.21389
Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.
William M Lydiatt (2017)
10.1016/j.path.2016.10.007
Human Papillomavirus-Associated Neoplasms of the Head and Neck.
Aaron M. Udager (2017)
10.1001/jamaoncol.2016.1804
Incidence of Oropharyngeal Cancer Among Elderly Patients in the United States.
Zachary S Zumsteg (2016)
10.1016/j.joms.2017.05.008
Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.
Moustafa W Mourad (2017)
10.1016/j.vaccine.2012.06.083
The biology and life-cycle of human papillomaviruses.
John Doorbar (2012)
10.1016/j.oraloncology.2012.06.019
Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis.
Michael A O'Rorke (2012)
10.1158/0008-5472.CAN-12-2384
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.
Sofia Lyford-Pike (2013)
10.1111/jop.12416
Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
Atsumu Kouketsu (2016)
10.1016/j.semradonc.2011.12.004
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Kie Kian Ang (2012)
10.1002/food.19890330516
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr
D. w. R. Bleyl (1989)
10.1016/j.jcms.2014.04.022
The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview.
Maximilian Krüger (2014)
10.14639/0392-100X-621
Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on prevention
Anna Odone (2015)
10.1093/jnci/djp534
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Nubia Muñoz (2010)
for Disease Control and Prevention: number of HPV-attributable cancer cases per year
CDC Center (2017)
10.3332/ecancer.2015.533
E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective
Massimo Origoni (2015)
10.1186/s40463-016-0179-6
HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
Jason K Wasserman (2017)
10.1016/S0300-9785(83)80033-7
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis.
Kari Juhani Syrjänen (1983)
WHO classification of head and neck tumors. Lyon (France): IARC; 2017
AK El-Naggar (2017)
10.1097/MD.0000000000004228
Oral sex and oropharyngeal cancer
Nam P Nguyen (2016)
Oral sex and oropharyngeal cancer : the role of the primary care physicians
NP Nguyen (2016)
10.1097/PAS.0b013e318253a2d1
Validation of Methods for Oropharyngeal Cancer HPV Status Determination in US Cooperative Group Trials
Richard C K Jordan (2012)
10.1177/154405910708600202
The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus
Camille C R Ragin (2007)
10.1200/JCO.2013.54.5228
p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
Christine H. Chung (2014)
10.1016/J.YPED.2010.12.093
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
James A. Stockman (2012)
10.1186/1758-3284-2-15
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)
Farshid Dayyani (2010)
10.3238/arztebl.2013.0184
Human papilloma virus infection in head and neck cancer.
S. Tribius (2013)
10.1016/S1470-2045(14)70471-1
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Cathy Ndiaye (2014)
10.1158/0008-5472.CAN-13-2479
p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumors.
Rüveyda Dok (2014)
10.1067/moe.2001.115392
Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.
Craig S. Miller (2001)
10.1093/ije/dyp350
Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium.
Julia E. Heck (2010)
10.1007/s10552-017-0889-8
Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers
Pardis Javadi (2017)
The biology and life-cycle of human papillomaviruses. Vaccine 2012;30(Suppl 5):F55–70
J Doorbar (2012)
10.3892/or.2012.1755
High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
Maria Persson (2012)



This paper is referenced by
10.1016/j.amjoto.2019.06.003
Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Michael Wotman (2019)
10.1038/s41598-018-35723-7
Felis catus papillomavirus type-2 E6 binds to E6AP, promotes E6AP/p53 binding and enhances p53 proteasomal degradation
Gennaro Altamura (2018)
10.1007/s40336-019-00338-z
Sentinel lymph node biopsy in oral–oropharyngeal squamous cell carcinoma: standards, new technical procedures, and clinical advances
Ludovico Maria Garau (2019)
10.3390/ijerph15010110
STI Knowledge in Berlin Adolescents
Frederik Tilmann von Rosen (2018)
10.1111/coa.13122
Oropharyngeal squamous cell carcinoma induces an innate systemic inflammation, affected by the size of the tumour and the lymph node spread
Å Kågedal (2018)
10.1155/2016/7498706
HPV Infection and Prognostic Factors of Tongue Squamous Cell Carcinoma in Different Ethnic Groups from Geographically Closed Cohort in Xinjiang, China
Hua Zhang (2016)
10.1016/j.amjoto.2019.06.007
HPV status in patients with nasopharyngeal carcinoma in the United States: A SEER database study.
Michael Wotman (2019)
10.1038/s41416-018-0143-5
Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma
Anna Kaisa Kylmä (2018)
10.1186/s12889-019-7923-6
Exploring lay public and dental professional knowledge around HPV transmission via oral sex and oral cancer development
Mario A. Brondani (2019)
10.1016/J.SEMERG.2019.03.004
Consideraciones sobre etiopatogenia y prevención del cáncer orofaríngeo
Eduardo Chimenos-Küstner (2019)
10.1080/0284186X.2020.1759822
Rate of locoregional recurrence among patients with oropharyngeal squamous cell carcinoma with known HPV status: a systematic review.
Jasmin Asheer (2020)
10.6004/jnccn.2017.0101
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
David Adelstein (2017)
10.1371/journal.pone.0235065
Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas
Larisse Silva Dalla Libera (2020)
10.1016/j.adaj.2020.02.010
Reducing the risk of oral cancer.
A. Musen Mark (2020)
10.1186/s13027-019-0268-z
HPV-related oropharyngeal cancer prevalence in a middle eastern population using E6/E7 PCR
Christopher A Maroun (2020)
10.1007/978-3-030-04702-3_22
Lymphedema in Head and Neck Cancer
Brad G. Smith (2019)
10.3389/fvets.2020.00148
Telomerase Reverse Transcriptase (TERT) Expression, Telomerase Activity, and Expression of Matrix Metalloproteinases (MMP)-1/-2/-9 in Feline Oral Squamous Cell Carcinoma Cell Lines Associated With Felis catus Papillomavirus Type-2 Infection
Gennaro Altamura (2020)
10.20344/amp.12191
Oral Transmission of Sexually Transmissable Infections: A Narrative Review.
Catarina Queirós (2019)
10.1007/978-3-030-32316-5_4
Human Papillomavirus Infection: A Risk Factor for Oral and Oropharyngeal Cancers
Giuseppina Campisi (2020)
10.1371/journal.pone.0194107
HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients’ survival
Miren Taberna (2018)
10.1002/hed.25337
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
10.1111/vco.12569
Detection of Felis catus papillomavirus type-2 DNA and viral gene expression suggest active infection in feline oral squamous cell carcinoma.
Gennaro Altamura (2020)
10.3390/ijms19061706
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis
Nicole Shu Ling Yeo-Teh (2018)
10.1007/s12285-017-0137-y
Einfluss onkogener Viren beim oralen Plattenepithelkarzinom
Andreas Kolk (2018)
Semantic Scholar Logo Some data provided by SemanticScholar